Humanigen Inc (HGENQ)

[cowtown jay]

I doubt that there are many patients who are happy with whatever asthma or arthritis drug they are taking. I'm not. So a therapeutic that can alleviate symptoms far better than what is currently available would be widely welcomed.

With our LIVE-AIR results being as stellar as they are, no BP is going to lend any credence to the findings of ACTIV-5. They are going to recognize the NIH/NIAID folly for what it is.

All BP needs to do is to model the LIVE-AIR trial design, and a DSMB would halt the trial at an interim review, and recommend FDA approval.